Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Longitudinal changes in quality of life and related psychosocial variables in australians with multiple sclerosis.
Chronic over-expression of TGFβ1 alters hippocampal structure and causes learning deficits.
Multiple sclerosis, natalizumab, and PML: helping patients decide.
Thymic Atrophy and Apoptosis of CD4+CD8+ Thymocytes in the Cuprizone Model of Multiple Sclerosis.
Effectiveness of muscle basal lamina carrying neural stem cells and olfactory ensheathing cells in spinal cord repair.
[Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald Criteria 2010: Commentary.
Acute hypoxic-ischemia in cardiac arrest encephalopathy causes only minimal demyelination.
High-intensity resistance training in multiple sclerosis - An exploratory study of effects on immune markers in blood and cerebrospinal fluid, and on mood, fatigue, health-related quality of life, muscle strength, walking and cognition.
New clinical insights into combined central and peripheral demyelination (CCPD).
Fluoxetine in Progressive Multiple Sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.
MRI outcomes in the diagnosis and disease course of multiple sclerosis.
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: No.
Clinical Outcome of 50 Progressive Multiple Sclerosis Patients Treated with Cellular Therapy in Iraq.
Multiple sclerosis: A clinically useful genetic variant in multiple sclerosis?
[Anesthetic Management of Three Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
[Clinical course and prognosis of multiple sclerosis].
Vitamin D deficiency and its role in neurological conditions: A review.
Ultrahigh-Field MR (7 T) Imaging of Brain Lesions in Neuromyelitis Optica.
Female sex hormones and cytokine secretion in women with multiple sclerosis.
A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination.
Relapsing MS patients more satisfied with Novartis oral drug Gilenya(TM) than standard injectable therapies, according to new study results at CMSC
Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-beta.
Association analysis of nitric oxide synthases: NOS1, NOS2A and NOS3 genes, with multiple sclerosis.
Role of Autoantibodies in Acquired Inflammatory Demyelinating Diseases of the Central Nervous System in Children.
Pages
« first
‹ previous
…
632
633
634
635
636
637
638
639
640
…
next ›
last »